STARTVAC
Emulsion for injection for cattle
STATEMENT OF THE ACTIVE SUBSTANCES:
One dose (2 ml) contains:
Escherichia coli (J5) inactivated > 50 RED60*
Staphylococcus aureus (CP8) inactivated, expressing Slime Associated Antigenic
Complex (SAAC) > 50 RED80**
* RED60: Rabbit effective dose in 60% of the animals (serology).
** RED80: Rabbit effective dose in 80% of the animals (serology).
STARTVAC is an ivory-coloured homogeneous emulsion for injection.
INDICATIONS:
For herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence and the severity of the symptoms of clinical or sub-clinical mastitis caused by Staphylococcus aureus, coliforms and coagulase-negative staphylococci. The full immunisation scheme induces immunity from approximately day 13 after the rst injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).
CONTRAINDICATIONS:
None.
ADVERSE REACTIONS:
Slight to moderate transient local reactions may occur after the administration of one dose of vaccine. They would mainly be: swelling (up to 5 cm2 on average), which disappears within 1 or 2 weeks at most. In some cases, there may also be pain at the inoculation site that spontaneously subsides in a maximum of 4 days. A mean transient increase in body temperature of about 1 °C, in some cows up to 2 °C, may occur in the rst 24 hours after injection. Animals immunised with an overdose did not show adverse reactions other than those observed after the administration of one dose of vaccine If you notice any serious effects or other effects not mentioned in this lea‑et, please inform your veterinary surgeon.
TARGET SPECIES:
Cattle (cows and heifers).
STARTVAC
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION:
Intramuscular use. The vaccinations should be preferably administered on the alternate sides of the neck. Administer one dose (2 ml) by deep intramuscular injection in the neck muscles and
According to the following schedule:
- First vaccination at 45 days before the expected parturition date.
- Second vaccination 35 days thereafter (corresponding to 10 days before the expected parturition date).
- Third vaccination 62 days after the second vaccination (booster vaccination). The full vaccination program should be repeated with each gestation.
ADVICE ON CORRECT ADMINISTRATION:
Allow the vaccine to reach a temperature of +15 to +25 °C before administration. Shake before use.
WITHDRAWAL PERIOD:
Zero days.
SPECIAL STORAGE PRECAUTIONS:
Keep out of the sight and reach of children. Store and transport refrigerated (+2 to +8 °C) and protected from light.
Do not freeze.
Do not use after the expiry date stated on the label.Shelf-life after rst opening the immediate packaging: 10 hours stored at roomtemperature (+15 to +25 ºC).
SPECIAL WARNING(S):
The whole herd should be immunised. Immunisation has to be considered as one component in a complex mastitis control program that addresses all important udder health factors (e.g. milking technique, dry-off and breeding management, hygiene, nutrition, housing, bedding, cow comfort, air and water quality, health monitoring) and other management practices. Special precautions for use in animals Only healthy animals should be vaccinated. Special precautions to be taken by the person administering the veterinary medicinal product to animals
To the user:
This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or nger, and in rare cases could result in the loss of the affected nger if prompt medical attention is not given.If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package lea‑et with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of nger pulp or tendon. Can be used during pregnancy and lactation. No information is available on the safety and efcacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Do not mix with any other vaccine or immunological product.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE
MATERIALS:
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
OTHER INFORMATION:
Pack sizes:
- Cardboard box with 1, 10 and 20 vials of 1 dose.
- Cardboard box with 1 and 10 vials of 5 doses.
- Cardboard box with 1 and 10 vials of 25 doses.